InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register account icon
S&P 500
5,529.56
(
-1.05%
)
US TECH 100
19,147.59
(
-0.64%
)
Dow Jones
40,650.17
(
-1.33%
)
Brent Oil
84.04
(
-0.53%
)
Bitcoin
63,504.58
(
-0.91%
)
Post# of 252638
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Replies (2) Keep Next 10 Report Keyboard Shortcuts
Replies (2) Next 10 Prev Next

iandy

Send PM Follow Ignore
Followers 18
Posts 3165
Boards Moderated 0
Alias Born 06/09/2010

iandy

Re: masterlongevity post# 120707

Saturday, 05/28/2011 9:31:34 AM

Saturday, May 28, 2011 9:31:34 AM

Post# of 252638
>In the same post-hoc, bapineuzumab did not show benefit over PBO on ANY measure in the carrier population<

Why would they do Phase 3 on a population that showed no benefit in Phase 2?
Public Reply Private Reply New Post
Keep Last Read
Replies (2) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (2) Next 10 Prev Next
Join InvestorsHub

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up